MENU
+Compare
AVBP
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$20.77
Change
-$0.33 (-1.56%)
Capitalization
762.16M

AVBP ArriVent BioPharma Forecast, Technical & Fundamental Analysis

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers... Show more

AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AVBP with price predictions
Jul 03, 2025

Aroon Indicator for AVBP shows an upward move is likely

AVBP's Aroon Indicator triggered a bullish signal on June 27, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 69 similar instances where the Aroon Indicator showed a similar pattern. In of the 69 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVBP advanced for three days, in of 75 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AVBP moved out of overbought territory on June 17, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AVBP as a result. In of 17 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AVBP turned negative on June 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 10 similar instances when the indicator turned negative. In of the 10 cases the stock turned lower in the days that followed. This puts the odds of success at .

AVBP moved below its 50-day moving average on July 01, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVBP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AVBP broke above its upper Bollinger Band on June 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.764) is normal, around the industry mean (16.648). P/E Ratio (0.000) is within average values for comparable stocks, (58.447). AVBP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.259). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (268.529).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AVBP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AVBP is expected to report earnings to fall 60.00% to -75 cents per share on August 13

ArriVent BioPharma AVBP Stock Earnings Reports
Q2'25
Est.
$-0.76
Q1'25
Missed
by $1.17
Q4'24
Missed
by $0.14
Q3'24
Missed
by $0.07
Q2'24
Missed
by $0.14
The last earnings report on May 12 showed earnings per share of -189 cents, missing the estimate of -73 cents. With 286.03K shares outstanding, the current market capitalization sits at 762.16M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18 Campus Boulevard
Phone
+1 628 277-4836
Employees
40
Web
https://arrivent.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGSIX80.301.03
+1.30%
BlackRock Technology Opportunities Instl
ALTFX154.241.17
+0.76%
AB Sustainable Global Thematic A
WAGSX13.290.08
+0.61%
Wasatch Global Select Investor
RMGSX11.400.03
+0.26%
Russell Inv Multi-Asset Strat S
SVXCX60.230.13
+0.22%
Smead International Value C

AVBP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with SYRE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
-1.56%
SYRE - AVBP
46%
Loosely correlated
+1.68%
LGND - AVBP
42%
Loosely correlated
+0.81%
DNLI - AVBP
42%
Loosely correlated
-1.41%
COGT - AVBP
42%
Loosely correlated
+2.29%
ATXS - AVBP
42%
Loosely correlated
+1.40%
More